Polymyxin B and colistimethate are comparable as to efficacy and renal toxicity

Diagnostic Microbiology and Infectious Disease

Volumn 65, Issue 4, 2009, Pages 431-434

  Oliveira, Maura S ^a   Prado, Gladys V B ^a   Costa, Silvia F ^a   Grinbaum, Renato S ^b   Levin, Anna S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL DO SERVIDOR PÚBLICO ESTADUAL DE SÃO PAULO   (Brazil)

Author keywords

Antibiotics; Drug resistance; Polymyxins

Indexed keywords

AMIKACIN; AMPHOTERICIN B; AMPICILLIN; CARBAPENEM; CEPHALOSPORIN; CIPROFLOXACIN; COLISTIMETHATE; COTRIMOXAZOLE; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; VANCOMYCIN;

ACINETOBACTER; ACINETOBACTER INFECTION; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEPHROTOXICITY; PRIORITY JOURNAL; SCHOOL CHILD; STATISTICAL ANALYSIS;

ACINETOBACTER INFECTIONS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; COLISTIN; FEMALE; HUMANS; KIDNEY; MALE; MIDDLE AGED; POLYMYXIN B; TREATMENT OUTCOME; YOUNG ADULT;

EID: 71549166622     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2009.07.018     Document Type: Article

References (9)

1. Bellomo R., Ronco C., Kellum J.A., Mehta R.L., Palevsky P., and Acute Dialysis Quality Initiative workgroup. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit. Care 4 (2004) R204-R212
2. Falagas M.E., and Kasiakou S.K. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit. Care 10 (2006) R27
3. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., and Hughes J.M. CDC definitions for nosocomial infections. Am. J. Infect. Control 16 (1988) 128-140
4. Levin A.S. Treatment of Acinetobacter spp infections. Expert Opin. Pharmacother. 4 (2003) 1289-1296
5. Li J., Nation R.L., Turnidge J.D., Milne R.W., Coulthard K., Rayner C.R., and Paterson D.L. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect. Dis. 9 (2006) 589-601
6. Michalopoulos A., and Falagas M.E. Colistin and polymyxin B in critical care. Crit. Care Clin. 24 (2008) 377-391
7. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-fourth edition, M7-A4 (1996), NCCLS, Wayne, PA
8. Oliveira M.S., Prado G.V., Costa S.F., Grinbaum R.S., and Levin A.S. Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp. J. Antimicrob. Chemother. 61 (2008) 1369-1375
9. Zavascki A.P., Goldani L.Z., Li J., and Nation R.L. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review. J. Antimicrob. Chemother. 60 (2007) 1206-1215